Posted by Michael Wonder on 06 Feb 2021
FDA announces Advisory Committee meeting to discuss Janssen Biotech’s COVID-19 vaccine candidate
4 February 2021 - The U.S. FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee on 26 February 2021, to discuss the request for emergency use authorization for a COVID-19 vaccine from Janssen Biotech.
The FDA intends to issue a Federal Register notice as soon as possible with details of the meeting, which will include information about a public docket for comments.
At that time, public comments can be submitted.
